SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

MDA Space Ltd. is an international space mission partner company, which engages in the provision of advanced technology, solutions, and services to the burgeoning global space industry. It operates through the following business areas: Geointelligence, Robotics and Space Operations, and Satellite Systems. The Geointelligence business area offers end-to-end solutions and services related to EO and intelligence systems. The Robotics and Space Operations business area enables humanity’s exploration and development of space infrastructure by providing autonomous robotics and vision sensors that operate in space and on the surfaces of the Moon and Mars. The Satellite Systems business area is involved in the sub-systems and spacecraft to enable space-based technology, solutions, and services, including next generation communication technologies that will deliver space-based broadband Internet and direct satellite-to-device connectivity from non geostationary orbit, which includes LEO and MEO, satellite constellations as well as solutions that span across the full communication frequency spectrum. The company was founded on June 2, 2020 and is headquartered in Brampton, Canada.

MDA Space Ltd.

MDA Ltd

Investors are actively debating the long-term potential of MDA Ltd as a foundational pick-and-shovel space play, drawing comparisons to peers like Rocket Lab and AST SpaceMobile. The community conversation centers on the companys ongoing satellite infrastructure projects, recent financial results, and the perceived undervaluation of its assets within the rapidly expanding global space sector.

MDA Space is drawing significant investor interest as a dual-listed player in the growing space infrastructure and robotics sector, with the community frequently highlighting its perceived undervaluation compared to U.S.-based peers. Discussion remains highly active regarding the company's long-term potential, including its critical role in international moon missions and speculation surrounding future acquisition activity or industry-wide sector boosts.

Schwab Strategic Trust - Schwab US Dividend Equity ETF

Schwab US Dividend Equity ETF

Schwab US Dividend Equity ETF (SCHD) is currently trending as investors rotate toward defensive, income-generating strategies, with community sentiment shifting to favor its role as a steady, dividend-growth anchor amidst market volatility. Discussion is heavily focused on long-term accumulation, the benefits of automatic dividend reinvestment, and the ETF's performance relative to higher-growth tech sectors.

Twenty One Capital, Inc. is focused on Bitcoin-related business. It offers shareholders a differentiated opportunity to gain exposure to Bitcoin through the equity markets. The company was founded on March 7, 2025 and is headquartered in Austin, TX.

Twenty One Capital Inc. - Ordinary Shares- Class A

Twenty One Capital Inc

Twenty One Capital is seeing significant market activity as investors digest its debut as a Bitcoin-focused powerhouse, backed by a massive treasury and partnerships with major industry players. The community is actively debating the company's valuation relative to its Bitcoin holdings and the potential for long-term growth driven by an integrated platform of mining, lending, and financial services.

Zcash is a privacy-focused cryptocurrency that uses trustless zero-knowledge proofs to enable fully encrypted transactions while maintaining blockchain transparency and security. It was the first cryptocurrency to implement zero-knowledge encryption for private peer-to-peer payments, addressing the fundamental privacy gap in traditional cryptocurrencies that expose transaction details publicly.   With a fixed supply of 21 million ZEC and a halving schedule similar to Bitcoin, Zcash allows users to prove transactions are valid without revealing sensitive information like wallet balances, transaction amounts, or participant identities, making it suitable for everyday payments, long-term savings, and cross-border money transfers where financial confidentiality matters.  The protocol operates on its own blockchain currently using Proof-of-Work consensus, though it's evolving toward Proof-of-Stake through the planned "Crosslink" upgrade to enhance security, scalability, and energy efficiency. Zcash employs trustless zero-knowledge proofs (Halo) within its Orchard shielded pool to verify transactions without revealing sender, receiver, or amount information.   Users can choose between transparent public transactions and shielded private transactions through Unified Addresses, which work with both types. The network is faster and cheaper than Bitcoin, with new blocks mined every 75 seconds and transaction fees typically just a fraction of a cent. Privacy adoption has surged in 2025, with over 30% of total ZEC supply now held in fully shielded pools.  Zcash was created by a group of scientists in 2013 who initially proposed Zerocoin as a privacy extension to Bitcoin before building a standalone protocol. The ecosystem operates with a self-funded development model where block rewards support independent teams through the Zcash Community Grants Committee and a new Coinholder-Controlled Fund.

Zcash

Zcash is trending as investors monitor technical breakout attempts and ongoing discussions around its long-term potential as a privacy-focused alternative to Bitcoin. Community sentiment remains highly polarized, with active debates between bulls highlighting technical milestones and future utility versus bears anticipating volatility or potential pullbacks.

USELESS

USELESS is trending as traders debate its extreme volatility and speculative potential, with the community polarized between those betting on a parabolic run to a billion-dollar valuation and others dismissing the asset as fundamentally meritless. Despite skepticism regarding its lack of utility, the project continues to generate buzz through active social media campaigns, cross-chain expansion efforts, and claims of institutional accumulation.

Bitwise Hyperliquid ETF - Bitwise Hyperliquid ETF

Bitwise Hyperliquid ETF

The Bitwise Hyperliquid ETF is trending as investors rally behind its direct exposure to the Hyperliquid ecosystem and anticipation surrounding new share offerings to facilitate token purchases. The community is actively discussing the fund as a generational opportunity, with many citing institutional buying activity and the project's perceived utility as a primary catalyst for the current momentum.

Guardant Health, Inc. is a precision oncology company, which engages in the provision of treatment of cancer through the use of proprietary blood-based tests, vast data sets, and advanced analytics. Its solutions include treatment selection, recurrence detection, and early detection. The company was founded by Helmy Eltoukhy, AmirAli H. Talasaz, and Michael Joseph Wiley in December 2011 and is headquartered in Palo Alto, CA.

Guardant Health Inc

Guardant Health (GH) is seeing strong bullish momentum driven by the FDA approval of its Guardant360 Liquid CDx, a significant expansion of its liquid biopsy capabilities. The community is actively discussing the test's potential as a market-leading screening tool and highlighting strong institutional support as institutional investors hold a significant majority of the shares.

Unicycive Therapeutics, Inc. is a biotechnology company, which engages in developing novel treatments for kidney diseases. The firm investigational treatment is oxylanthanum carbonate, a novel phosphate binding agent currently under review by the U.S. Food and Drug Administration (FDA) for the treatment of hyperphosphatemia in patients with chronic kidney disease who are on dialysis. Unicycive’s second investigational treatment UNI-494 is intended for the treatment of conditions related to acute kidney injury. It has been granted orphan drug designation (ODD) by the FDA for the prevention of Delayed Graft Function (DGF) in kidney transplant patients and has completed a Phase 1 dose-ranging safety study in healthy volunteers. The company was founded by Shalabh Gupta on August 18, 2016 and is headquartered in Los Altos, CA.

Unicycive Therapeutics Inc

Unicycive Therapeutics is trending as investors monitor the company's efforts to resolve manufacturing deficiencies following a Complete Response Letter, with community members closely tracking the upcoming Type A meeting with the FDA for a clear path to NDA resubmission. While some investors remain optimistic about the drug's potential for reducing pill burden and improving compliance, others are expressing frustration over management communication, the impact of recent dilution, and the extended timeline toward a potential 2026 approval.

Super Group (SGHC) Ltd. is a global digital gaming company, which engages in the global online sports betting and gaming businesses, Betway, a premier online sports betting brand, and Spin, a multi-brand online casino offering. It operates through the following segments: Betway, Spin, and Other. The Betway segment focuses on the ingle brand online sportsbook and online casino focused business with a global footprint and strategic partnerships. The Spin segment relates to the multi-brand online casino focused business with established market leadership in high-growth markets. The company was founded in July 2020 and is headquartered in St. Peter Port, the United Kingdom.

Super Group (SGHC) Limited

Super Group (SGHC) is actively trending as investors analyze the firm's recent earnings beat, raised full-year guidance, and the introduction of a special dividend. Community sentiment remains highly focused on the stock's valuation relative to its debt-free balance sheet, with many shareholders debating the potential impact of new venture investments and geopolitical headwinds.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

This $4 Million Bet Shows Growing Confidence in 10x Genomics as Stock Surges 116%

Key PointsQuantedge Capital added 212,600 shares of 10x Genomics in the first quarter; the estimated transaction value was $4.25 million based on quarterly average pricing...

10x Genomics Q1 Earnings & Revenues Beat Estimates, Gross Margin Up

TXG beats Q1 estimates as consumables growth, margin expansion and lower operating costs narrow losses year over year.

10x Genomics (TXG) Q1 2026 Earnings Transcript

@media (max-width: 768px) {
 .image-container {
 width: 100% !important;
 float: none !important;
 margin: 0 0 1rem 0 !important;
 }
 }

Image source: The Mo...

10x Genomics (TXG) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates

While the top- and bottom-line numbers for 10x Genomics (TXG) give a sense of how the business performed in the quarter ended March 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

10x Genomics (TXG) Reports Q1 Loss, Beats Revenue Estimates

10x Genomics (TXG) delivered earnings and revenue surprises of +65.52% and +3.57%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

10x Genomics Reports First Quarter 2026 Financial Results

10x Genomics Reports First Quarter 2026 Financial Results 10x Genomics Reports First Quarter 2026 Financial Results PR Newswire PLEASANTON, Calif., May 7, 2026 PLEASANTON, Calif., May 7, 2026...

PacBio Pre-Q1 Analysis: Time to Buy, Hold or Sell the Stock Now?

PACB heads into Q1 earnings with strong consumables momentum, but muted academic demand and macro pressures cloud near-term visibility.

Hims & Hers Health, Inc. (HIMS) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release

Hims & Hers Health (HIMS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

M&T Bank Corp Has $1.19 Million Stake in 10x Genomics $TXG

M&T Bank Corp boosted its stake in 10x Genomics (NASDAQ:TXG - Free Report) by 258.5% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 73,188 shares of the company's stock after purchasing an additional 52,771 shares du...

10x Genomics (TXG) Expected to Beat Earnings Estimates: Should You Buy?

10x Genomics (TXG) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

10X Genomics, Inc. is a life science technology company, which engages in building products to interrogate, understand and master biology. Its integrated solutions include single cell transcriptomics, single cell genomics, single cell epigenomes, linked-reads genomics and spatial transcriptomics. The company’s products include Single Cell Gene Expression, Immune Profiling, ATAC, and Genome. The company was founded by Serge Saxonov, Ben Hindson and Kevin D. Ness on July 2, 2012 and is headquartered in Pleasanton, CA.

TXG
10x Genomics Inc - Ordinary Shares - Class A

Feed

News

Sentiment

Earnings

Fundamentals

Info

Compact View

Latest TXG News

TXG10x Genomics Inc - Ordinary Shares - Class A